A string of infant formula and food recalls tied to bacterial contamination has kept the FDA and USDA’s Food Safety and Inspection Service busy through 2026, underscoring how caregivers and clinicians who work with home tube-feeding and infant nutrition should approach recall alerts.
Several powdered infant formula products have been linked this year to multistate outbreaks of infant botulism, caused by Clostridium botulinum contamination. The FDA has been investigating shared ingredient suppliers across affected products, and has separately warned the infant formula industry to strengthen supplier oversight following a global contamination event in late 2025 and early 2026 involving cereulide, a heat-stable bacterial toxin found in contaminated arachidonic acid (ARA) oil used in some formulas.
On the conventional food side, USDA’s Food Safety and Inspection Service (FSIS) has issued a series of public health alerts and recalls in 2026 covering products contaminated with Salmonella, Listeria monocytogenes, and Cyclospora — including a public health alert in August tied to jalapeños used across a range of meat and poultry products, and downstream recalls of prepared foods that used the affected ingredient.
The FDA has been conducting expanded testing of infant formula for contaminants under its “Closer to Zero” initiative, reporting that the large majority of samples showed undetectable or very low contaminant levels.
What does this mean for someone managing a patient’s or family member’s nutrition? First, a recall notice does not automatically mean a product currently in your home or your patient’s supply is affected — recalls are typically limited to specific lot numbers, date codes, or manufacturing sites, and the manufacturer’s or FDA’s own recall notice is the authoritative source for checking whether a specific product is included. Registered dietitians working with tube-fed or formula-dependent patients should build a habit of checking FDA.gov’s recall listings and USDA FSIS recall pages directly rather than relying on secondhand reports, since the details that matter — lot numbers, “best by” dates, distribution regions — are only reliable at the source.
Second, for any product tied to a Salmonella, Listeria, or Clostridium botulinum concern, the standard food-safety response applies regardless of the specific brand: stop using the product, do not taste it to check whether it “seems fine,” and follow the manufacturer’s or retailer’s return or disposal instructions. Symptoms of infant botulism — constipation, poor feeding, a weak cry, and loss of head control — warrant immediate medical attention, since the condition can progress quickly in infants.
Finally, the FDA’s own testing data offers some reassurance alongside the vigilance: the agency’s expanded infant formula surveillance under “Operation Stork Speed” found that most samples tested had undetectable or very low levels of contaminants, and the agency has said it plans to issue draft guidance on acceptable action levels for heavy metals like cadmium and inorganic arsenic in foods marketed for babies and young children. Staying current on both the recalls and the broader safety data is part of the job for any clinician managing nutrition-dependent patients.